Volgen
Suzanne Epstein
Suzanne Epstein
Associate Director for Research, FDA, CBER, OTATT
Geverifieerd e-mailadres voor fda.hhs.gov
Titel
Geciteerd door
Geciteerd door
Jaar
Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
G Franzoso, L Carlson, L Poljak, EW Shores, S Epstein, A Leonardi, ...
The Journal of experimental medicine 187 (2), 147-159, 1998
5671998
Protection against lethal influenza virus challenge by RNA interference in vivo
SM Tompkins, CY Lo, TM Tumpey, SL Epstein
Proceedings of the National Academy of Sciences 101 (23), 8682-8686, 2004
5512004
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1
SM Tompkins, ZS Zhao, CY Lo, JA Misplon, T Liu, Z Ye, RJ Hogan, Z Wu, ...
Emerging infectious diseases 13 (3), 426, 2007
3852007
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein, W Kong, JA Misplon, CY Lo, TM Tumpey, L Xu, GJ Nabel
Vaccine 23 (46-47), 5404-5410, 2005
3842005
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature
SL Epstein
The Journal of infectious diseases 193 (1), 49-53, 2006
3382006
Mechanism of protective immunity against influenza virus infection in mice without antibodies
SL Epstein, CY Lo, JA Misplon, JR Bennink
The Journal of Immunology 160 (1), 322-327, 1998
2291998
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection
I Jelinek, JN Leonard, GE Price, KN Brown, A Meyer-Manlapat, ...
The Journal of Immunology 186 (4), 2422-2429, 2011
2282011
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice
SL Epstein, TM Tumpey, JA Misplon, CY Lo, LA Cooper, K Subbarao, ...
Emerging infectious diseases 8 (8), 796, 2002
2262002
Critical roles for the Bcl-3 oncoprotein in T cell–mediated immunity, splenic microarchitecture, and germinal center reactions
G Franzoso, L Carlson, T Scharton-Kersten, EW Shores, S Epstein, ...
Immunity 6 (4), 479-490, 1997
2131997
Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of …
NA Giese, L Gabriele, TM Doherty, DM Klinman, L Tadesse-Heath, ...
The Journal of experimental medicine 186 (9), 1535-1546, 1997
1921997
Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells
KA Benton, JA Misplon, CY Lo, RR Brutkiewicz, SA Prasad, SL Epstein
The Journal of Immunology 166 (12), 7437-7445, 2001
1722001
Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
SL Epstein, CY Lo, JA Misplon, CM Lawson, BA Hendrickson, EE Max, ...
Journal of immunology (Baltimore, Md.: 1950) 158 (3), 1222-1230, 1997
1691997
Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
GE Price, MR Soboleski, CY Lo, JA Misplon, C Pappas, KV Houser, ...
Vaccine 27 (47), 6512-6521, 2009
1552009
Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses
GE Price, MR Soboleski, CY Lo, JA Misplon, MR Quirion, KV Houser, ...
PloS one 5 (10), e13162, 2010
1452010
Antigen-antibody interaction and monoclonal antibodies
IA Berzofsky
Fundamental immunology, 421-425, 1993
1231993
Cross-protective immunity to influenza A viruses
SL Epstein, GE Price
Expert review of vaccines 9 (11), 1325-1341, 2010
1192010
Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
SL Epstein, JA Misplon, CM Lawson, EK Subbarao, M Connors, ...
Journal of immunology (Baltimore, Md.: 1950) 150 (12), 5484-5493, 1993
1161993
Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies
CY Lo, Z Wu, JA Misplon, GE Price, C Pappas, WP Kong, TM Tumpey, ...
Vaccine 26 (17), 2062-2072, 2008
982008
Induction of anti-H–2 antibodies without alloantigen exposure by in vivo administration of anti-idiotype
JA Bluestone, SO Sharrow, SL Epstein, K Ozato, DH Sachs
Nature 291 (5812), 233-235, 1981
801981
Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza
N Arinaminpathy, O Ratmann, K Koelle, SL Epstein, GE Price, C Viboud, ...
Proceedings of the National Academy of Sciences 109 (8), 3173-3177, 2012
792012
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20